.
BUDGET 2012
 | News | Market | Portfolio | Messages
SENSEX  26,360.11  45.82
NIFTY  7,891.10  15.80
Go to Moneycontrol Home
Pharmaceuticals
Cipla Q1 profit falls 39% on weak operational performance
Consolidated revenue grew by 8.3 percent to Rs 2,720 crore in the quarter ended June 2014 from Rs 2,511 crore in same qu
Abbott India Q1 profit rises 71% to Rs 51 cr
Maintain 13-15% growth guidance for full year: Sun Pharma
Why capex of top 20 Indian pharma firms is set to jump 40%
Sun Pharma posts Q1 profit at Rs 1,390 cr
GlaxoSmithKline Pharma Q2 net down 14.56% to Rs 98.29 crore
Expect margins around 32-35% going forward: Suven Life
STOCK RECOMMENDATION
Stock Advice
Remain invested in Ipca Laboratories: Ashu Madan
Stay with Ranbaxy Laboratories: Hemen Kapadia
Hold Ranbaxy Laboratories, says Ashu Madan
more
Broker Reports
Buy Divis Labs; target of Rs 1633: ICICIdirect
Hold Sun Pharma; target of Rs 800: KRChoksey
Buy Aurobindo Pharma; target of Rs 874: PLilladher
more
Budget 2012
HOME
Font Size: S M L
Mobile | Classic
Customer Support
© 2011. a Web18 Venture